Microscopic and biochemical analysis of anomalous white fibrous clots from deceased mRNA Injection Recipients
Gold-standard analytical techniques reveal a potential novel infectious amyloid pathology associated with Spike protein exposure.
May 09, 2025
In this eye-opening interview, I sit down with embalmer Richard Hirschman and industrial chemist Greg Harrison to investigate the emergence of large, white fibrous clots in deceased individuals who received COVID-19 mRNA injections.
Hirschman, a seasoned embalmer with over 20 years of experience, first began noticing these unusual white, rubbery clots in early 2021. Found in both veins and arteries—a rarity in embalming practice—their frequency and composition were unlike anything he had encountered in two decades of work.
To better understand what they were made of, he partnered with Greg Harrison, an industrial organic chemist with deep expertise in polymer analysis. Harrison subjected the clots to rigorous biochemical testing using techniques like ICP-MS, HPLC, Raman spectroscopy, and RT-QuIC.
What they uncovered is nothing short of shocking: these are not ordinary post-mortem clots. The structures are composed of misfolded fibrin proteins with amyloid characteristics—including signs of infectious amyloid behavior, capable of triggering misfolding in other proteins. These findings raise grave concerns about a novel, systemic disease process that may be silently affecting millions:
What’s Inside These Clots?
Not Normal Clots:
These are not “chicken fat clots” or ordinary post-mortem artifacts. Richard Hirschman, who has embalmed thousands of bodies, began finding these anomalies only after the COVID-19 mRNA injection rollout in 2021 — not during the height of the COVID pandemic in 2020.
For the rest of this article please go to source link below.
Video can be accessed at source link below.